A new treatment of alopecia induced by palbociclib: Topical cetirizine.

Author: CarlesimoMarta, CaroGemma, FedericoAlessandro, FortunaMaria C, MagriFrancesca, RossiAlfredo

Paper Details 
Original Abstract of the Article :
INTRODUCTION: Recently CDK4/6 inhibitors have been introduced for the treatment of hormone positive breast cancer resistant to endocrine therapy. Among their side effects, alopecia is often reported being associated to patients' distress and depressive symptoms. CASE REPORT: We report the case of a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/1078155220930334

データ提供:米国国立医学図書館(NLM)

Topical Cetirizine: A Potential Solution for Alopecia Induced by Palbociclib

Palbociclib, a medication used to treat breast cancer, can sometimes cause hair loss (alopecia), a distressing side effect for many patients. This study reports a case of a patient who experienced alopecia while taking palbociclib and found relief with the application of topical cetirizine, an antihistamine. It's like a traveler finding a hidden oasis in the desert, offering a temporary respite from the harsh conditions.

A Novel Approach to Alopecia Management

This case report offers a promising approach to managing palbociclib-induced alopecia. The use of topical cetirizine, a common antihistamine, suggests a potential solution for this challenging side effect. This discovery could lead to new avenues for managing hair loss in patients undergoing cancer treatment.

Implications for Cancer Treatment Side Effects

The findings of this case report highlight the importance of exploring new and creative approaches to managing the side effects of cancer treatments. This could significantly improve the quality of life for patients undergoing chemotherapy or other therapies. The journey toward alleviating the burden of cancer treatment side effects continues, offering hope for patients seeking a better quality of life.

Dr. Camel's Conclusion

This case report is a reminder that even in the arid landscape of cancer treatment, there are often unexpected oases of relief. Topical cetirizine may offer a valuable solution for managing palbociclib-induced alopecia, providing hope for patients seeking to regain their hair and enhance their overall well-being.

Date :
  1. Date Completed 2021-03-29
  2. Date Revised 2021-03-29
Further Info :

Pubmed ID

32529951

DOI: Digital Object Identifier

10.1177/1078155220930334

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.